Skip to main content

Table 3 CSF Analysis on Biweekly 40 mg IT Trastuzumab (Total 80 mg Weekly)

From: Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient

Week 1 2 3 4
Protein (g/L) 34 28 33 26 30 31 61a
RBC (/cmm3) <1 1 <1 1 <1 1 1
WBC (/cmm3) <1 <1 <1 1 2 1 <1
  1. CSF samples were obtained prior to IT Trastuzumab injection
  2. IT intrathecal, CSF cerebrospinal fluid, RBC red blood cell, WBC white blood cell
  3. aindicates high CSF protein